|
CCDC93 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.49560397189452E-14 |
| Normal-vs-Stage2 |
1.88929999977994E-07 |
| Normal-vs-Stage3 |
4.71844785465692E-14 |
| Normal-vs-Stage4 |
1.5340999581781E-09 |
| Stage1-vs-Stage2 |
9.161800E-01 |
| Stage1-vs-Stage3 |
1.067990E-01 |
| Stage1-vs-Stage4 |
3.860400E-01 |
| Stage2-vs-Stage3 |
2.396400E-01 |
| Stage2-vs-Stage4 |
4.644200E-01 |
| Stage3-vs-Stage4 |
7.477800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55111512312578E-16 |
| Normal-vs-AfricanAmerican |
2.16499999999842E-05 |
| Normal-vs-Asian |
1.65850000000134E-06 |
| Caucasian-vs-AfricanAmerican |
6.724400E-01 |
| Caucasian-vs-Asian |
1.088980E-01 |
| AfricanAmerican-vs-Asian |
4.900400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.35695965154082E-13 |
| Normal-vs-Female |
1.62536650805123E-12 |
| Male-vs-Female |
9.498000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.93101090673053E-12 |
| Normal-vs-Age(41-60Yrs) |
1.30717658919366E-12 |
| Normal-vs-Age(61-80Yrs) |
3.3442137947759E-12 |
| Normal-vs-Age(81-100Yrs) |
6.761600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.883800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.299000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.699600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.125000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.332400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.524600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.379090E-03 |
| Classical-VS-Follicular |
1.585780E-01 |
| Classical-VS-Other |
3.166200E-01 |
| Classical-VS-Normal |
3.15729997701908E-09 |
| Tall-VS-Follicular |
8.464300E-02 |
| Tall-VS-Other |
6.807600E-01 |
| Tall-VS-Normal |
5.6005200477216E-12 |
| Follicular-VS-Other |
6.569000E-01 |
| Follicular-VS-Normal |
2.85420020951221E-10 |
| Other-VS-Normal |
1.079810E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.29101199017623E-13 |
| Normal-vs-N1 |
3.16829995572476E-09 |
| N0-vs-N1 |
5.648200E-01 |
|
|
